Trial Profile
Phase I trial of darleukin in combination with fibromun in head and neck cancer patients
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 21 Jan 2016
Price :
$35
*
At a glance
- Drugs Bifikafusp alfa (Primary) ; Onfekafusp alfa
- Indications Head and neck cancer
- Focus Adverse reactions
- Sponsors Philogen
- 21 Jan 2016 New trial record